Anna Bettini

5.1k citations
27 papers · 902 · 1 hit paper · h-index 11

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
  • Oncology top 10%
    • Lung Cancer Research Studies
    • HER2/EGFR in Cancer Research
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers

Papers in

Anna Bettini

27 papers receiving 883 citations

Anna Bettini's Hit Papers

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial 2013 · 381 citations
3810+4+8Years since publication100200300

Peers

Anna Bettini
Comparison fields: 5 of 46
  • Pulmonary and Respiratory Medicine 477
  • Oncology 396
  • Cancer Research 159
  • Pathology and Forensic Medicine 61
  • Radiology, Nuclear Medicine and Imaging 74
Replace Claudia Omarini with:
Claudia Omarini Italy
Shugeng Gao China
Ullas Batra India
Olivier Bouché France
Noriaki Sukoh Japan
Tadaaki Nishikawa Japan
M. Veslemes Greece
Jacob Sands United States
Thomas Goddemeier Germany
Hiroshi Suehisa Japan
Anna Bettini relative to Claudia Omarini Italy Claudia Omarini's profile →
Citations per field
00.5×2×4×5.7×
Claudia Omarini · 1×
Citations per year

Countries citing papers authored by Anna Bettini

Since Specialization
Citations

This map shows the geographic impact of Anna Bettini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Bettini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Bettini more than expected).

Fields of papers citing papers by Anna Bettini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Bettini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Bettini. The network helps show where Anna Bettini may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Bettini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Bettini Line = papers co-authored together Anna Bettini links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial
Hit paper breakdown →
2013381
2 2003100
3 201577
4 201366
5 201244
6 201541
7 200232
8 201432
9 202124
10 201222
11 200811
12 201510
13 20149
14 20179
15 20086
16 20036
17 20205
18 20205
19 20205
20 20114

About Anna Bettini

Anna Bettini is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Pathology and Forensic Medicine and Molecular Biology, having authored 27 papers that have together received 902 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Genomics and Diagnostics (3 papers), Breast Cancer Treatment Studies (3 papers), Genetic factors in colorectal cancer (3 papers), DNA Repair Mechanisms (2 papers), COVID-19 and healthcare impacts (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (477 citations), Oncology (396 citations), Cancer Research (159 citations), Pathology and Forensic Medicine (61 citations) and Radiology, Nuclear Medicine and Imaging (74 citations). Anna Bettini has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Marina Chiara Garassino, Monica Ganzinelli, Calogero Lauricella, Mirko Marabese, Massimo Broggini, Gabriella Farina, Eliana Rulli, Silvia Marsoni, Silvio Veronese and Roberto Labianca. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, ESMO Open, Journal of Clinical Medicine and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact